EMVIGR LIMITED

Financial Health Assessment: EMVIGR LIMITED

1. Financial Health Score: B+

Explanation: The patient is in fundamentally good condition, possessing a robust immune system (strong cash reserves) and zero debt. However, the recent shrinkage in net assets suggests the business is currently consuming more energy than it is generating, resulting in a mild but noticeable deterioration in overall financial weight. It is healthy, but showing symptoms of underperformance.

2. Key Vital Signs

• Liquidity (Blood Pressure): Excellent. Current Assets stand at £38,706 against Current Liabilities of £0. This yields an infinite current ratio. The company has absolutely no short-term debt pressure; its financial blood is flowing freely with no blockages.
• Solvency (Heart Rate): Strong. Net Assets are £41,444. The company owes nothing to external creditors (Total Liabilities are £0), meaning the entire asset base belongs to the shareholders. The heart is pumping steadily without the strain of debt.
• Asset Trajectory (Weight/Muscle Mass): Declining. Net assets dropped from £47,297 in 2024 to £41,444 in 2025—a loss of £5,853 (a 12.4% decrease). Similarly, Current Assets fell from £45,112 to £38,706. The patient has lost weight, which requires investigation to determine if it is healthy fat-burning (efficiency) or muscle-wasting (loss-making).
• Revenue (Caloric Intake): Intermittent. Turnover was only visible for 2023 at £10,050. This is a very low caloric intake for a business, suggesting it may be operating as a lifestyle business or relying on lumpy, project-based income.
• Capital Circulation: Minor Irregularity. The balance sheet shows £100 of "Called up share capital not paid." This is a minor administrative irregularity—like a slight heart murmur—meaning the shareholders haven't officially paid for their initial shares. It is harmless but worth tidying up.

3. Diagnosis

Overall Condition: Stable but experiencing mild atrophy.

The financial data reveals a business with an exceptionally strong balance sheet relative to its size, characterized by a complete absence of debt and healthy cash reserves. Think of this patient as someone with zero bad cholesterol and a strong resting heart rate.

However, the symptoms reveal an underlying issue: the business is shrinking. The drop in net assets from 2024 to 2025 indicates that the company ran at a loss during this period, or the directors withdrew funds as dividends (which reduces retained earnings). Because the company files as a Micro-Entity, we do not have the full Profit & Loss "blood panel" to confirm whether this was an operational loss or a dividend withdrawal, but the effect is the same—the business body is consuming its own reserves.

The nature of the business (software development—SIC 62011) often involves periods of heavy investment followed by revenue generation. However, with an average of only 2 employees and very low turnover figures historically, this appears to be a lean operation that is currently in a dormant or low-activity phase, relying on past reserves to survive.

4. Recommendations

1. Identify the Hemorrhage: Determine the cause of the £5,853 drop in net assets. If it was a trading loss, review whether the business model is still viable or if costs need cutting. If it was a dividend withdrawal, ensure that the company is generating enough "new blood" (revenue) to replace what was taken out.
2. Nutritional Plan (Revenue Generation): With turnover historically low, the business needs a strategy to increase its caloric intake. Relying on cash reserves to fund ongoing operations is like living off savings; eventually, the reserves will deplete. Explore new markets or products to stimulate income.
3. Exercise Capital (Investment): The company has £38,706 in Current Assets (likely mostly cash) sitting idle. While this provides an excellent safety net, excessive idle cash is like unused muscle—it atrophies over time due to inflation. Consider whether a portion of this could be invested in growth to generate higher returns.
4. Clear the Murmur: Resolve the £100 unpaid share capital. It is a minor administrative issue, but paying it in cleans up the balance sheet and ensures formal compliance is pristine.